Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2003
08/28/2003WO2002083063A3 Method of improving systemic exposure of subcutaneously administered therapeutic proteins
08/28/2003WO2002078717A3 Compositions and methods for reducing rna virus pathogenicity
08/28/2003WO2002077021A3 Streptococcus pneumoniae proteins and nucleic acids
08/28/2003WO2002074783A3 Modified interferon beta with reduced immunogenicity
08/28/2003WO2002070006A3 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
08/28/2003WO2002054073A3 Latent human tuberculosis model, diagnostic antigens, and methods of use
08/28/2003WO2002046749A3 Screening method for identifying compounds that selectively induce interferon alpha
08/28/2003WO2002043771A3 Conjugates of glycosylated/galactosylated peptide
08/28/2003WO2002038174A3 Vaccines containing recombinant hantavirus proteins, methods for producing said vaccines and their use
08/28/2003WO2002036627A3 Interferons, uses and compositions related thereto
08/28/2003WO2002036149A3 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof
08/28/2003WO2002020050A3 Eiav p26 deletion vaccine and diagnostic
08/28/2003WO2002000839A3 Statement as to federally sponsored research
08/28/2003WO2000042994A3 Inhibition of bacterial dissemination
08/28/2003US20030163845 Elongase genes and uses thereof
08/28/2003US20030162968 1,4-Disubstituted benzo-fused urea compounds
08/28/2003US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162836 Microbiocides
08/28/2003US20030162831 14-O-((cycloalkyl-sulfanyl)acetyl)-, 14-O-((cycloalkyl-alkyl-sulfanyl)acetyl)-, 14-O-((cycloalkoxy)acetyl)- and 14-O-((cycloalkyl-alkoxy) acetyl) mutilins; microbiocides
08/28/2003US20030162819 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
08/28/2003US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
08/28/2003US20030162808 Acetindine derivatives, their preparation and medicaments containing them
08/28/2003US20030162800 Nitrogen compounds such as 10-Butyl-8-chloro-10-(trifluoro methyl)-5,10-dihydropyrimido(5,4-b)quinolin-4(3H)-one, used as polymerase inhibitors for prophylaxis of viral diseases
08/28/2003US20030162794 Benzazole derivatives and their use as jnk modulators
08/28/2003US20030162786 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein
08/28/2003US20030162779 4-oxo-4H-thiazole derivative for treating or preventing neurodegenerative disorders
08/28/2003US20030162775 Heterocyclic substituted pyrazolones
08/28/2003US20030162767 Novel 1,3-dihydro-2h-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them
08/28/2003US20030162763 Antibacterial agent, particularly against strains such as methicillin-resistant Staphylococcus aureus
08/28/2003US20030162762 Novel cephalosporin compounds and process for preparing the same
08/28/2003US20030162743 Matrix metalloproteinase and tumor necrosis factor inhibitors
08/28/2003US20030162730 Crystal forms of azithromycin
08/28/2003US20030162709 Methods of generating multispecific, multivalent agents from VH and VL domains
08/28/2003US20030162300 Galactomannan-oligosaccharides and methods for the production and use thereof
08/28/2003US20030162206 Central nervous system disorders; antiinflammatory agnets; antidiabetic agents
08/28/2003US20030162196 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030161888 Pharmaceutical Composition
08/28/2003US20030161883 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis
08/28/2003US20030161863 Administering mixtures of nutrients for prophylaxis of muscular, metabolic or respiratory disorders, injuries, inflammation and/or to relieve stress
08/28/2003US20030161850 Agent for inhibiting adhesion of the pathogenic flora of the skin
08/28/2003US20030161845 A chimeric Arterivirus composed of parts originating from at least two different arteriviruses where a stretch of nucleic acids encoding a non-Arteriviris protein fragment is inserted in the full genome; vaccines; veterinary medicine; swine
08/28/2003US20030161834 Adjuvant compositions comprising a saponin and and an immunostimulatory oligonucleotide containing unmethylated CpG (a cytosine guanosine dinucleotide DNA motif); synergistic induction of antigen; anticarcinogenic agents
08/28/2003US20030161828 Use of TNF antagonists as drugs for the treatment of patients with an inflammatory reaction and without suffering from total organ failure
08/28/2003US20030161826 Therapy for autoimmune disease; central nervous system disorders
08/28/2003US20030161820 Prevent infections; antiulcer agents
08/28/2003US20030161811 Method for treating cervical cancer
08/28/2003US20030161809 Complexes; drug delivery
08/28/2003US20030159914 Plant extracts from fruit pits; presoaking in water, distillation; separation by specific gravity; bactericides, antiseptics; sterilization
08/28/2003DE29924428U1 New topical composition for treating herpes family viruses, reduces treatment-related erythema but maintains high activity
08/28/2003CA2513192A1 Nucleotide sequence coding for a tolc and a defined amino acid sequence
08/28/2003CA2512020A1 Compositions and methods for delivery of skin cosmeceuticals
08/28/2003CA2489498A1 An antimicrobial agent
08/28/2003CA2485882A1 A therapeutic agent for mycobacterium tuberculosis comprising 15k granulysin as the active ingredient
08/28/2003CA2477195A1 Deleted sequence in m. tuberculosis, method for detecting mycobacteria using these sequences and vaccines
08/28/2003CA2477191A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
08/28/2003CA2477014A1 Rna interference mediated inhibition of tnf and tnf receptor superfamily gene expression using short interfering nucleic acid (sina)
08/28/2003CA2476956A1 Strategy for retroviral immunotherapy
08/28/2003CA2476935A1 Drug delivery system for subconjunctival administration of fine particles
08/28/2003CA2476854A1 Surrogate antibodies and methods of preparation and use thereof
08/28/2003CA2476822A1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003CA2476764A1 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003CA2476452A1 Electroporation methods for introducing bioactive agents into cells
08/28/2003CA2476451A1 Hyaluronic acid mediated adenoviral transduction
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/28/2003CA2476427A1 Partial peptide mimetics and methods
08/28/2003CA2476406A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
08/28/2003CA2476394A1 Rna interference mediated inhibition of hiv gene expression using short interfering nucleic acid (sina)
08/28/2003CA2476376A1 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
08/28/2003CA2476112A1 Rna interference mediated inhibition of interleukin gene expression using short interfering nucleic acid (sina)
08/28/2003CA2475437A1 Methods for producing .gamma..delta. t cells
08/28/2003CA2475310A1 Antimicrobial streptococcus salivarius strain and use thereof for preventing dental caries
08/28/2003CA2474848A1 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003CA2474671A1 Methods for determining the influence of protein binding on antiretroviral activity
08/28/2003CA2473100A1 Pyranones useful as atm inhibitors
08/28/2003CA2473089A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003CA2473078A1 Method for producing interferon
08/28/2003CA2463595A1 Rna interference mediated inhibition of bcl2 gene expression using short interfering nucleic acid (sina)
08/28/2003CA2459532A1 Rna interference by modified short interfering nucleic acid
08/27/2003EP1338657A1 Sequences specifcally deleted from Mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
08/27/2003EP1338607A2 Antigenic iron repressible proteins from n. meningitidis related to the heolysin family of toxins
08/27/2003EP1338599A1 Optically pure analogues of Camptothecin
08/27/2003EP1338596A1 Process for producing carbapenem-type antibacterial
08/27/2003EP1338307A1 Chemical and biological decontamination material and system
08/27/2003EP1338286A1 Use of extracts from plants of the family Zosteraceae for the prevention and therapy of bacterial and viral infections
08/27/2003EP1338282A1 Uridine derivatives as Matrix Metalloproteinase (MMP) and Tumor Necrosis Factor (TNF) inhibitors for the treatment of cancer
08/27/2003EP1338281A1 Method for producing an immunotropic antiviral preparation
08/27/2003EP1337647A2 Helicobacter cysteine rich protein a (hcpa) and uses thereof
08/27/2003EP1337634A2 Novel polypeptides involved in immune response
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337550A2 Hepatitis c tripeptide inhibitors
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337539A2 Linkable sialyl lewis x analogs
08/27/2003EP1337530A1 Oxazolidinones having a benzannulated 6-or 7-membered heterocycle as antibacterial agents
08/27/2003EP1337529A2 Heterocyclylalkyl piperidine derivatives, their preparation and compositions containing same
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337525A1 Process for the crystallization of (r)- or (s)-lansoprazole
08/27/2003EP1337517A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
1 ... 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 ... 1798